Authors: GOEDHALS L HERON JF KLEISBAUER JP PAGANI O SESSA C GIGER K CAVALLI F LUDWIG C AAPRO M BLEIBERG H DEWASH G DICATO M TAGNON A VANSTRAELEN D VINDEVOGHEL A ABRATT R FALKSON G BARLEY V CARMICHAEL J COLEMAN R DAVIDSON N GRIEVE R HARPER P ROBERTS J RUSTIN G NAMAN H SCHNEIDER M NOBLE A NETTER P CUPISSOL D BALMES P CALS L KHAYAT D CATIMEL G DUTIN JP BOUFETTE P ADENIS L MISSET J COLLERY P NOUVET G CHAVAILLON JM BLANCHON F POIRIER R ARNAUD A LECAER H CARLES P MUIR J BONNAUD F MARQUESTE L CLAVIER J GUERIN J TAYTARD A KEIZER H NORTIER J SLEE P WILS J RODENBURG C BURGHOUTS J DEWIT R GARCIAGIRON C JIMENEZLACAVE A CRUZHERNANDEZ J MASSUTISUREDA B HANS K FUCHS R KRIEGMAIR M SCHULLER J LAHOUSEN M PANNUTI F MONFARDINI S NILSSON S

Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666

Authors: CHEVALLIER B CAPPELAERE P SPLINTER T FABBRO M WENDLING JL CALS L CATIMEL G GIOVANNINI M KHAYAT D BASTIT P CLAVERIE N

Citation: B. Chevallier et al., A DOUBLE-BLIND, MULTICENTER COMPARISON OF INTRAVENOUS DOLASETRON MESILATE AND METOCLOPRAMIDE IN THE PREVENTION OF NAUSEA AND VOMITING IN CANCER-PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Supportive care in cancer, 5(1), 1997, pp. 22-30

Authors: COLLARD O PERRAUD P MELANI C NOUYRIGAT P CALS L

Citation: O. Collard et al., PSEUDOTUMORAL PELVIC ACTINOMYCOSIS, La Presse medicale, 25(16), 1996, pp. 776-776

Authors: AAPRO M PIGUET D GIGER K BAUER J HAEFLIGER JM BREMER K CALS L CATTAN A CLAVEL M CZYGAN P DEARNALEY D DIEHL V HARJUNG M HARPER P ILLIGER H KAYE S KEIZER HJ KERBRAT P KONIG HJ MONCUQUET P DEBESANCON C NAMER M NOBEL A NORTIER JWR OBERLING F PLAGNE R REICHLE A RIVIERE A SOUKOP M VEENHOF CHN ZYLBERAIT D HUNTER B

Citation: M. Aapro et al., THE ANTIEMETIC EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING FRACTIONATED CHEMOTHERAPY OVER 5 DAYS, Journal of cancer research and clinical oncology, 119(9), 1993, pp. 555-559